Epstein–Barr virus (EBV), hepatitis B virus (HBV), human T-lymphotropic virus 1 (HTLV-1), human papillomaviruses (HPVs), hepatitis C virus (HCV), Kaposi sarcoma-associated herpesvirus (KSHV; also known as human herpesvirus 8 (HHV-8)) and Merkel cell polyomavirus
Viruses and Cancer: Introduction to OncovirusesAparna Dubey
The presentation describes about Oncoviruses or the cancer causing viruses with emphasis on HPV ( Human papillomavirus ) responsible for Cervical Cancer.
here i discussed some human oncogenic viruses , their epidemeology, life cycle, treatment, prevention and control. . oncogenic viruses are cancer causing viruses.
Viruses and Cancer: Introduction to OncovirusesAparna Dubey
The presentation describes about Oncoviruses or the cancer causing viruses with emphasis on HPV ( Human papillomavirus ) responsible for Cervical Cancer.
here i discussed some human oncogenic viruses , their epidemeology, life cycle, treatment, prevention and control. . oncogenic viruses are cancer causing viruses.
An oncovirus is a virus that can cause cancer. This term originated from studies of acutely transforming retroviruses in the 1950–60s, often called oncornaviruses to denote their RNA virus origin. It now refers to any virus with a DNA or RNA genome causing cancer and is synonymous with "tumor virus" or "cancer virus".
What is virus History of viruses Virus components How viruses act on genetic material Basic principles What is cancer TWO BASIC MECHANISMS Normal cell cycle ONCOGENES AND TUMOR SUPPRESSORGENES CONTROL THE CELL CYCLE Proto ontogenesis and normal cell division CONCEPT OF ONCOGENES
An oncogene is a gene that has the potential to cause cancer. In tumor cells, these genes are often mutated or expressed at high levels. Most normal cells will undergo a programmed form of rapid cell death (apoptosis) when critical functions are altered and malfunctioning
Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. These contrast with benign tumors, which do not spread to other parts of the body.
## To understand how cancer develops and progresses, researchers first need to investigate the biological differences between normal cells and cancer cells. This work focuses on the mechanisms that underlie fundamental processes such as cell growth, the transformation of normal cells to cancer cells, and the spread, or metastasis, of cancer cells.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
An oncovirus is a virus that can cause cancer. This term originated from studies of acutely transforming retroviruses in the 1950–60s, often called oncornaviruses to denote their RNA virus origin. It now refers to any virus with a DNA or RNA genome causing cancer and is synonymous with "tumor virus" or "cancer virus".
What is virus History of viruses Virus components How viruses act on genetic material Basic principles What is cancer TWO BASIC MECHANISMS Normal cell cycle ONCOGENES AND TUMOR SUPPRESSORGENES CONTROL THE CELL CYCLE Proto ontogenesis and normal cell division CONCEPT OF ONCOGENES
An oncogene is a gene that has the potential to cause cancer. In tumor cells, these genes are often mutated or expressed at high levels. Most normal cells will undergo a programmed form of rapid cell death (apoptosis) when critical functions are altered and malfunctioning
Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. These contrast with benign tumors, which do not spread to other parts of the body.
## To understand how cancer develops and progresses, researchers first need to investigate the biological differences between normal cells and cancer cells. This work focuses on the mechanisms that underlie fundamental processes such as cell growth, the transformation of normal cells to cancer cells, and the spread, or metastasis, of cancer cells.
Similar to oncogenic viruses by dr rahul acharya.pptx (20)
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
2. Distinguishing
Characteristics of Viruses
Obligate intracellular
parasites
Extreme genetic
simplicity
Contain DNA or RNA
Replication involves
disassembly and
reassembly
Replicate by "one-step
growth”
2
3. Viruses enter the body of the host
in a variety of ways, for example...
3
5. WHO Estimates
Worldwide, the WHO International
Agency for Research on Cancer estimated
that in 2002, 20% of human cancers were
caused by infection, of which 10–15% are
caused by one of seven different viruses.
The importance of this is that some of
these cancers might be easily prevented
through vaccination
5
6. What is Cancer
Cancer results from alterations in critical
regulatory genes that control cell
proliferation, differentiation, and survival.
Studies of tumor viruses revealed that
specific genes (called oncogenes) are
capable of inducing cell transformation,
thereby providing the first insights into
the molecular basis of cancer.
6
7. How virus causes Cancers:
The viral agents causing cancer in eukaryotic
animals by integrating in host genome
*A virus associated with malignancies in natural host,
experimental animals or cell cultures.
*viruses which modified proto-oncogene, obligatory
host specific, with the ability immortalization,
possess genes which stimulate growth and cause
cancer.
7
8. Early History
The theory that cancer could be caused
by a virus began with the experiments
of Oluf Bang and Vilhelm Ellerman in
1908 who first show that avian
erythroblastosis (a form of chicken
leukemia) could be transmitted by cell-
free extracts. This was subsequently
confirmed for solid tumors in chickens
in 1910-1911 by Peyton Rous. 8
9. Research History
In 1908, Ellerman &
Bang first discovered
virus, producing
leukemia in chicken.
In 1911 Peyton Rous 1st
shows the presence of
filterable sarcoma
material that induce the
CANCER.
9
11. Relationship of viruses with
malignancy
Ellerman & Bang (1908) – leukemia in
fowls
Rous (1911) – fowl sarcoma
Shope isolated Rabbit fibroma virus
(1932), papilloma virus (1933)
Bittner (1936) –Breast Ca in mice
11
12. Understanding Cancer
CANCER
Cancer is an overgrowth of cells bearing
cumulative genetic injuries that confer growth
advantage over the normal cells [Nowell’s
Law]
Cancer cells can be characterized as
antisocial, fairly autonomous units that
appear to be indifferent to the constraints
and regulatory signals imposed on normal
cells [Robbin’s]
12
13. Oncovirus
An oncovirus is a virus that can cause
cancer. This term originated from
studies of acutely-transforming
retroviruses in the 1950–60s, often
called oncornaviruses to denote their
RNA virus origin. It now refers to any
virus with a DNA or RNA genome
causing cancer and is synonymous with
"tumor virus" or "cancer virus". 13
14. by transforming cells
cancer
• When a virus infects a cell, it
expresses proteins that cause the
cell to proliferate and/or block
apoptosis
• Cancer is multi-factorial: Oncogenic
viruses are very common, only a small
% of people infected actually get
cancer
14
16. Oncogenic viruses may be RNA or DNA
20% of human
cancers believed to be
of viral origin
These include:
Cervical cancer
Burkitt’s lymphoma
Hepatocarcinoma
Kaposi’s sarcoma
Virus is not only
factor
16
17. Major human Oncogenic Viruses
17
DNA Viruses
Small DNA tumor viruses
- Adenovirus
- SV40
- Human Papilloma virus (HPV)
Herpesviruses (large)
- Epstein Barr virus (EBV)
- Kaposi’s Sarcoma Herpesvirus (KSHV)
Other
- Hepatitis virus B
RNA viruses
Human T-cell Leukemia Virus 1 (HTLV1)
Hepatitis virus C
18. Viruses Associated With The
Development Of Human Neoplasia
VIRUSES NEOPLASMS
DNA VIRUSES
Human papilloma virus Cervical Ca, warts, ano-
genital carcinoma
Herpes simplex virus II Cervical carcinoma
Epstein-Barr virus NPCa, African Burkitt’s
Human Herpes virus 8 Kaposi’s sarcoma
Hepatitis B virus Hepatocellular Ca
Herpes simplex virus 6 Certain B cell
lymphomas
(HBLV)
Molluscipoxvirus molluscum 18
19. Viruses Associated With The
Development Of Human Neoplasia
VIRUSES NEOPLASMS
RNA VIRUSES
Human T-cell leukemia virus I Some T-cell leukemia,
Lymphoma
Human T-cell leukemia virus II Some cases of hairy
cell leukemia
Human immunodeficiency virus Lymphoma; Kaposi’s
sarcoma
Hepatitis virus Hepatocellular
carcinoma
19
20. • Oncogenic viruses
Oncogenesis is the result of
genetic changes that alter the
expression or function of
proteins that play critical roles
in the control of cell growth
and division
•Oncogenic viruses cause
cancer by inducing changes
that affect cell growth and
division
20
21. Oncogenic Retroviruses
More than 40 different highly oncogenic retroviruses
have been isolated from a variety of animals, including
chickens, turkeys, mice, rats, cats, and monkeys. All of
these viruses, like RSV, contain at least one oncogene
In some cases, different viruses contain the same
oncogenes, but more than two dozen distinct
oncogenes have been identified among this group of
viruses
21
22. Changes in cell that are at the roots of
cancer
22
Genetic and epigenetic alterations:
• Mutations
• Deletions
• Recombination's
• Transpositions
• Epigenetic alterations (DNA methylation,
imprinting)
• Acquisition of viral genetic material
• Various combinations of these lead to the development
of cancers - some viruses contribute single hits while
others contribute multiple hits.
23. 23
• Integrations that cause activation or
inactivation of oncogenes or tumor
suppressors (e.g. RNA viruses)
• Expression of genes that alter key
signal transduction pathways - this is our
focus
• Chronic activation of
inflammatory responses
How do Viruses contribute to
cancer?
24. Viral transformation can induce
cellular changes including
tumourigenicity
3/12/2023 Dr.T.V.Rao MD 24
26. Transformation and poential
tumorigenesist
Transformation - alteration in a cell’s properties that leads to
immortalization and different growth patterns that result
from alteration in cell cycle
Loss of anchorage dependence
Loss of contact inhibition (foci)
Decreased requirements for growth factors
Tumorigenesis (oncogenicity) - in vivo development of
tumors
26
28. Cancer
Cancer arises from
a combination of
dominant gain of
function mutations
in proto-
oncogenes and
recessive loss of
function mutations
in tumor
suppressor genes 28
29. CANCER CELLS AND NORMAL CELLS
29
CANCER CELLS NORMAL CELLS
Loss of contact inhibition
Increase in growth factor secretion
Increase in oncogene expression
Loss of tumor suppressor genes
Oncogene expression is rare
Intermittent or co-ordinated
growth factor secretion
Presence of tumor suppressor
genes
Normal
cell
Few
mitoses
Frequent
mitoses
Nucleus
Blood vessel
Abnormal
heterogeneous cells
30. CHARACTERISTICS OF CANCER
Clonality
Cancer is a genetic disease at the cellular
level.
Genetic mutations play a critical role in
pathogenesis of cancer.
Consequences of genetic instability:
Phenotypic heterogeneity
Tumor progression
Proto-oncogenes and oncogenes
Dominant and recessive mutations 30
31. Cancer Genetics
Tumors arise as clones from a single cell. At
the cellular level, cancer is a genetic disease.
The development of the malignant clone is
due to mutations in DNA due to:
Random replication errors
Exposure to carcinogens
Faulty DNA repair process
31
32. Cancer Genes
Proto-oncogenes – normally promote
normal cell growth; mutations convert
them to oncogenes.
Tumor suppressor genes – normally
restrain cell growth; loss of function
results in unregulated growth.
Mutator or DNA repair genes – when
faulty, result in an accumulated rate of
mutations.
32
33. ONCOGENE FAMILY
+ oncogenes
Oncogenes
promote cell proliferation
dominant & highly conserved
types: viral oncogenes [v-oncs]
cellular oncogenes [c-oncs]
Proto-oncogene “Mutation” Oncogene
Mouse fibroblast cell line NIH 3T3 can take up foreign D
Mouse fibroblast cell line NIH 3T3 can take up foreign DNA,
incorporate them into their genome and express them
•DNA extracted from human tumour cells can transform NIH 3T3
•Such transforming genes have been shown to be identical with cellular
oncogenes
14NA, incorporate them into their genome and express them
•DNA extracted from human tumour cells can transform NIH 3T3
•Such transforming genes have been shown to be identical with cellular
oncogenes
14
33
34. Viral Carcinogenesis
Viral carcinogens are classified
into RNA and DNA viruses.
Most RNA oncogenic viruses
belong to the family of
retroviruses that contain
reverse transcriptase
mediates transfer of viral RNA
into virus specific DNA.
34
35. 35
Two Major Classes of Tumor Viruses
DNA Tumor Viruses
DNA viral genome
Host RNA
polymerase
Viral mRNA
Viral protein
DNA-dependent
DNA polymerase
(Host or viral)
36. 36
RNA Tumor Viruses
Viral RNA genome
Reverse transcriptase (Virus-
encoded)
Viral DNA genome (integrated)
DNA-dependent RNA
polymerase (Host RNA pol II)
Viral genomic RNA
Splicing (Host splicing enzymes)
messenger RNA
viral protein
Virus
Important: Use HOST
RNA polymerase
to make its genome
An enzyme that normally
makes mRNA
IMPORTANT
37. Viruses causing human
malignancies
Hepatitis B & C viruses: Hepatocellular
Cancer.
E-B virus: Nasopharyngeal Ca, Burkitt’s
lymphoma
HPV 16 & 18: Ca Cx
HTLV: Adult T cell leukemia
HHV 8: Kaposi’s sarcoma
37
38. DNA Tumor Viruses In Human
Cancer
38
Adenoviruses
Highly oncogenic in animals
Only part of virus integrated
Always the same part
Early functions
E1A region: 2 T antigens
E1B region: 1 T antigen
E1A and E1B = Oncogenes
40. Retroviridae
Any virus capable of
inducing tumors. The
RNA tumor viruses
(family Retroviridae),
which are well defined
and rather
homogeneous, or the
DNA viruses, which
contain a number of
viruses capable of
inducing
40
41. 41
• Adenovirus
• Human virus but only causes cancer in non-
human cells
• SV40
• Mesothelioma
• HPV
• Cervical Cancer
• Squamous cell anal carcinoma
• Penile cancer
• Oral cancers
Small DNA tumor viruses
42. DNA Tumor Viruses In Human Cancer
42
Papilloma Viruses
urogenital cancer
wart malignant squamous cell
carcinoma
Papilloma viruses are found in 91% of women with cervical cancer
Squamous cell carcinoma:
Larynx
Esophagus All histologically similar
Lung
10% of human cancers may be HPV-linked
43. DNA Tumor Viruses In Human Cancer
43
Herpes Viruses
Considerable evidence for role in human cancer
• Some very tumorigenic in animals
• Viral DNA found in small proportion of tumor
cells: “hit and run”
• Epstein-Barr Virus
• Burkitt’s Lymphoma
• Nasopharyngeal cancer
• Infectious mononucleosis
• Transforms human B-lymphocytes in
44. DNA Tumor Viruses In Human
Cancer
Hepatitis B continued
44
Epidemiology:
Strong correlation
between HBV and
hepatocellular
carcinoma
45. DNA Tumor Viruses In Human Cancer
45
Papilloma Viruses
• 51 types identified - most common
are types 6 and 11
• most cervical, vulvar and penile
cancers are ASSOCIATED with types
16 , 18 & 31 (70% of penile cancers)
46. Human Papillomavirus (HPV)
Human Papillomavirus
(HPV) is a double-
stranded DNA virus of
the family Papovaviridae.
It infects only epithelial
cells in humans such as
skin and mucus
membranes. It can affect
the lower genital tract
including the vulva,
vagina, urethra, penis,
46
47. Human Papilloma virus
(HPV), causes transformation in cells
through interfering with tumor
suppressor proteins such as p53.
Interfering with the action of p53 allows
a cell infected with the virus to move into
a different stage of the cell cycle,
enabling the virus genome to be
replicated. Forcing the cell into the S
phase of the cell cycle could cause the
cell to become transformed types of HPV
47
49. quadrivalent recombinant vaccine
against HPV types 6, 11, 16 and 18
To prevent cervical cancers in children aged 9–15 years and
women from 16-26 years
expected to prevent up to 70% of
nearly 100 percent effective in preventing precancerous
cervical lesions, precancerous vaginal and vulvar lesions and
genital warts caused by infection with the HPV types 6, 11, 16
or 18 in women between the ages of 16 and 26.
49
50. Epstein Barr virus
50
Pathologies in immuno-competent individuals
• Infectious mononucleosis
• Burkitt’s Lymphoma
• Hodgkin’s lymphoma
• Nasopharyngeal carcinoma
Pathologies in immuno-compromised indiviuals
• Post-transplant lymphoproliferative diseases (PTLD)
• Hodgkin’s lymphoma
• A variety of non-Hodgkin’s lymphoblastic malignancies
51. Epstein-Barr virus (Human
herpes virus 4)
EBV is most strongly associated with
cancer. It infects primarily lymphocytes
and epithelial cells. In lymphocytes, the
infection is usually non-productive, while
virus is shed (productive infection) from
infected epithelial cells.
51
52. Burkitt's lymphoma
Burkitt's lymphoma in the tropics, where it is more
common in malaria-endemic regions
Nasopharyngeal cancer, particularly in China and SE
Asia, where certain diets may act as co-carcinogens
B cell lymphomas in immune suppressed individuals
(such as in organ transplantation or HIV)
Hodgkin's lymphoma in which it has been detected
in a high percentage of cases (about 40% of affected
patients)
X-linked lymphoproliferative Disease (Duncan's
syndrome)
52
53. Infectious mononucleosis
EBV also causes infectious mononucleosis,
otherwise known as glandular fever. This is
a self-resolving infection of B-lymphocytes
which proliferate benignly. Often infection
goes unnoticed (it is sub-clinical) and about
half of the population in western countries
has been infected by the time they reach 20
years of age. Why this virus causes a benign
disease in some populations but malignant
disease in others is unknown 53
55. Human Herpes Virus 8 (HHV-8,
Kaposi's Sarcoma Herpes Virus)
HHV-8 infects lymphocytes and epithelial/endothelial
cells and is the causative agent of Kaposi's sarcoma. It
has also been associated with hematologic
malignancies, including primary effusion lymphoma,
Multicentric Castleman's (also Castelman's) disease
(MCD), MCD-related immunoblastic/plasmablastic
lymphoma and various atypical lymphoproliferative
disorders
55
56. Kaposi's sarcoma-associated
herpesvirus
Kaposi's sarcoma-associated
herpesvirus (KSHV or HHV-8) is
associated with Kaposi’s sarcoma, a
type of skin cancer. Epstein-Barr virus
(EBV or HHV-4) is associated with four
types of cancers Merkel cell
polyomavirus – a polyoma virus – is
associated with the development of
Merkel cell cancer 56
57. RNA oncogenic viruses
Retroviridae
Human T cell leukemia viruses
(HTLV-1 and HTLV-2)
Causes
Adult T – cell leukemia
Lymphoma
Feline leukemia virus (FeLV)
Contagious
Causes leukemia and lymphoma in cats
Related to presence of reverse transcriptase
Some contain promoters that turn on other oncogenes
57
58. RNA Tumor Viruses
58
Groups of Retroviruses
• Oncovirinae
Tumor viruses and similar
• Lentiviruses
Long latent period
Progressive chronic disease
Visna HIV
• Spumavirinae
important
important
59. VIRAL AGENTS: DNA viruses
Human Papillomavirus [HPV types 16, 18, 31, 33 & 35]
Interruption of the E1/E2 ORF
E2 is not expressed
Over-expression of E6 & E7
59
60. VIRAL AGENTS: DNA viruses
Epstein-Barr Virus [EBV]
in Burkitt’s, B-cell & Hodgkin’s lymphomas + NP ca
tropism: CD21+ cells [e.g., B cells, epithelial cells]
mechanism: viral entry episomal existence latency
(+) LMP-1, EBNA-1, EBNA-2 immortalization
Hepatitis B virus [HBV]
induction of chronic hepatocyte injury (+) HBx
HBx activates protein kinase c for transformation
60
61. Hepatitis B
DNA virus with RNA
intermediate
In tumors virus is
integrated with little
gene expression
Believed to be from
chronic liver
damage/loss and
replacement causing
increased mutations
(similar to SOS
response?) 61
62. DNA Tumor Viruses In Human Cancer
62
Hepatitis B Virus
DNA genome
RNA polymerase II
RNA Provirus
Reverse transcriptase
DNA genome
Host enzyme
Viral enzyme
63. HEPADNAVIRIDAE
HEPATITIS B VIRUS
Hepatitis B virus is very different from the other DNA
tumor viruses. Indeed, even though it is a DNA virus, it is
much more similar to the oncornaviruses (RNA tumor
viruses) in its mode of replication. The DNA is transcribed
into RNA not only for the manufacture of viral proteins but
for genome replication. Genomic RNA is transcribed back
into genomic DNA. This is called reverse transcription. The
latter is not typical of most DNA tumor viruses but reverse
transcription is a very important factor in the life cycles of
RNA-tumor viruses
63
64. Hepatocellular carcinoma
Hepatocellular carcinoma (HCC, also called malignant
hepatoma) is a primary malignancy (cancer) of the liver.
Most cases of HCC are secondary to either a viral hepatic
infection (hepatitis B or C) or cirrhosis (alcoholism being the
most common cause of hepatic cirrhosis).In countries where
hepatitis is not endemic, most malignant cancers in the liver
are not primary HCC but metastasis (spread) of cancer from
elsewhere in the body, e.g., the colon.
64
65. RNA Tumor Viruses
65
• Human T cell lymphotropic virus -2 (HTLV-2)
Hairy cell leukemia
Retroviruses known to cause human cancer
• Human T cell lymphotropic virus -1 (HTLV-1)
Adult T cell leukemia, Sezary T-cell leukemia
Africa, Caribbean, Some Japanese Island
• HIV?
66. Proto-oncogenes
66
Heterozygote Homozygote
Allele 1 Allele 2 Allele 1 Allele 2
Normal Mutant Mutant Mutant
Function gained Function gained
Dominant
mutations
Binds under
special
circumstance
s
Mutant
always
binds
Mutant
always
binds
Mutant
always
binds
Always binds Always binds
67. Anti-Oncogenes
67
Rb Gene Mutant Rb Mutant Rb
Rb
Rb
Rb
protein
Binds and controls cell cycle No binding - Growth continues
Mutant Rb
Recessive mutations
Function lost
Mutation growth
Heterozygote Homozygote
69. RNA Tumor Viruses
69
What do oncogenes encode?
Proteins that are involved in growth control and
differentiation
Growth factors
Growth factor receptors
Signal transduction proteins
Transcription factors